|
Saturday Morning Breakfast served from 7.00am |
Sunday Morning Breakfast served from 7.30am |
| Abbott | Nevro | Saluda Medical |
Bursting with Progress: Charting a New Course in Neuromodulation
Abbott continues to push the boundaries of what is possible in Neuromodulation so join us to find out how! Over breakfast, uncover the latest breakthroughs in patient experience & outcomes, technology, and indications. Hear from leading panelists on impact of digital health in enhancing efficiencies & outcomes, advancements in lowering the profile of implantable devices, progress around personalized treatment and emergence of new indications.
Join Dr Kiran Patel, Director of Pain Medicine; Lennox Hill Hospital & Founder & CEO, NYC Neuromodulation Centre of Excellence, Dr Allen Burton, DVP & Chief Medical Officer, Abbott, Dr Chris Gilligan, Associate Chief Medical Officer & Pain Medicine Specialist, Dr Nathan Taylor, Interventional Pain Medicine Specialist, Northern Pain Centre and Dr Douglas Lautner, Director of Neuroscience & Software, Abbott, for a fantastic and indepth morning session.
Beyond Pain: Exploring Durable Real-World Patient Outcomes Driven by a Decade of Data from Belgium to Brisbane!
Join us for insightful presentations by Dr Iris Smet, chaired by Dr Frank Thomas. Hear from both physicians who have over 10 years of experience with Nevro HFX, from the SENZA EU RCT to over 10 years with real-world patients in practice from Belgium to Brisbane. Hear Q&A on what they believe the future of pain management outcomes could be with the power of big data.
Dr Iris Smet is educated in Anesthesia & Intensive Care Medicine and is a specialist for Pain Therapy at Hospital AZ Nikolaas in Belgium. As a staff member of the multidisciplinary pain center she is focussing on acute pain and chronic pain and has a huge experience in using different Spinal Cord Stimulation Systems.
Australian Innovation in Neuromodulation: Elevating technology and clinical evidence with Saluda’s SmartSCS™ Therapy
Australia-based and founded Saluda Medical is at the leading edge of innovation in neuromodulation with the world’s first and only ECAP-Controlled, Closed-Loop SCS – the Evoke® System. Chaired by Marc Russo, MBBS (AU) a panel of speakers including Jason Pope, MD (USA), Liam Ring, MBBS (AU), and Paul Verrills, MBBS (AU) will cover the foundational technology of Saluda’s SmartLoop™ Technology and key results from the landmark EVOKE Study- the only double-blinded, pivotal RCT with 36 month outcomes in SCS history.